Source: Annual Congress 2003 - Experimental and clinical studies on the pathogenesis and treatment of acute respiratory failure
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
M. Tarasenko, S. Kichemasov, A. Matveenko, A. Admakin, A. Bautin, E. Akulinov, D. Kallistov, I. Shpakov, I. Venevitinov, A. Tikhonov, O. Rosenberg (St Petersburg, Russia). Surfactant therapy for ALI developed at the background of deep burns and the burns of the respiratory tract. Eur Respir J 2003; 22: Suppl. 45, 549

Member's Comments

No comment yet.

Related content which might interest you: The management of severe sepsis in respiratory tract infections Source: Annual Congress 2013 –ME14 The management of severe sepsis in respiratory tract infections Year: 2013 Surfactant therapy for persistent atelectasis developed in the children with acute bronchopneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 629s Year: 2005 The respiratory microbiota during and following mechanical ventilation for respiratory infections in children Source: Eur Respir J, 57 (4) 2002652; 10.1183/13993003.02652-2020 Year: 2021 Surfactant therapy in acute lung injury/acute respiratory distress syndrome Source: Eur Respir Mon 2012; 55: 54-64 Year: 2012 Surfactant treatment leads to a sustained improvement of oxygenation only in severe pediatric ARDS without pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 318s Year: 2001 Antioxidant systems in rat trachea upon thermal and chemical burns of upper airway Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 Surfactant and inflammation in patients predisposed for ARDS after multiple trauma Source: Annual Congress 2004 - The fourth ERS - free paper symposium on interdisciplinary basic and clinical surfactant research Year: 2004 Does antibiotic treatment of upper respiratory tract infections prevent bacterial LRTIs? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Intrapulmonary penetration of antimicrobials and implications in treatment of lower respiratory tract infections Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009 Evaluation of antibiotics therapy for low respiratory tract infections Source: Eur Respir J 2007; 30: Suppl. 51, 406s Year: 2007 Principles of surfactant-therapy ARDS in patients with severe inhalation trauma Source: Annual Congress 2008 - Acute lung injury and weaning Year: 2008 Impact of bacterial colonization in lower respiratory tract on fibrile episode in patietns with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 1s Year: 2003 Asthma and acute infections of upper respiratory tract in children Source: Eur Respir J 2006; 28: Suppl. 50, 253s Year: 2006 Surfactant therapy for acute lung injury and other lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 210s Year: 2003 Effectiveness of an inspiratory pressure-limited approach to mechanical ventilation in septic patients Source: Eur Respir J 2013; 41: 157-164 Year: 2013 Role of heat shock proteins in the lungs of acute lung injury Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management Year: 2006 Impact of appropriate diagnostics on the management of respiratory tract infections Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021 Year: 2021 Fluoroquinolones and lower respiratory tract infections Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=94 Year: 2004 Fatal outcome in lower respiratory tract infections Source: Eur Respir J 2004; 24: Suppl. 48, 186s Year: 2004 Malacia, inflammation and bacterial colonisation of the conducting airways in infants with persistent respiratory symptoms Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy Year: 2011